<?xml version='1.0' encoding='UTF-8'?>
<oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><dc:title>Antileshmanial 2-substituted quinolines : in vitro behaviour towards biological components</dc:title><dc:creator>Desrivot, J.</dc:creator><dc:creator>Herrenknecht, C.</dc:creator><dc:creator>Ponchel, G.</dc:creator><dc:creator>Garbi, N.</dc:creator><dc:creator>Prina, E.</dc:creator><dc:creator>Fournet, Alain</dc:creator><dc:creator>Bories, C.</dc:creator><dc:creator>Figadère, B.</dc:creator><dc:creator>Hocquemiller, B.</dc:creator><dc:creator>Loiseau, P.M.</dc:creator><dc:subject>LEISHMANIOSE</dc:subject><dc:subject>PARASITE</dc:subject><dc:subject>METHODE DE LUTTE</dc:subject><dc:subject>MEDICAMENT</dc:subject><dc:subject>EFFICACITE</dc:subject><dc:subject>EXPERIMENTATION IN VITRO</dc:subject><dc:subject>CHROMATOGRAPHIE EN PHASE LIQUIDE</dc:subject><dc:subject>EXTRACTION</dc:subject><dc:subject>TEMPERATURE</dc:subject><dc:subject>ETUDE EXPERIMENTALE</dc:subject><dc:subject>ETUDE COMPARATIVE</dc:subject><dc:subject>QUINOLINE</dc:subject><dc:subject>PHARMACOCINETIQUE</dc:subject><dc:subject>CYTOTOXICITE</dc:subject><dc:subject>CONCENTRATION</dc:subject><dc:subject>HEMATOCRITE</dc:subject><dc:date>2007</dc:date><dc:type>text</dc:type><dc:identifier>http://www.documentation.ird.fr/hor/fdi:010040724</dc:identifier><dc:identifier>oai:ird.fr:fdi:010040724</dc:identifier><dc:identifier>Desrivot J., Herrenknecht C., Ponchel G., Garbi N., Prina E., Fournet Alain, Bories C., Figadère B., Hocquemiller B., Loiseau P.M. Antileshmanial 2-substituted quinolines : in vitro behaviour towards biological components. Biomedicine and Pharmacotherapy, 2007, 61 (7), p. 441-450. </dc:identifier><dc:language>EN</dc:language></oai_dc:dc>
